# Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4

Canonical: https://abierto.us/opportunities/darpasn2691

- Solicitation number: DARPA-SN-26-91
- Notice type: Special notice
- Status: Closed. Deadline was June 29, 2026
- Department: Department of Defense
- Agency: Defense Advanced Research Projects Agency
- Contracting office: Def Advanced Research Projects Agcy (HR0011)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AC12 National Defense R&D Services; Department Of Defense - Military; Applied Research
- First posted: June 11, 2026
- Last posted: June 11, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/61a78b0d91244a65b239a1248a80e7af/view

## Description

The Defense Advanced Research Projects Agency (DARPA) is seeking support for commercialization of technologies to be developed under the upcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. The purpose of this announcement is to notify the community of the RAPIID commercialization goals, initiate dialogue to address program needs, and share the timetable for full proposal submission. This special notice is released under the current DARPA BTO Office Wide Broad Agency Announcement (BAA) HR001126S0003, titled “Biological Technologies.”

## Publications

- June 11, 2026: Special notice, due June 29, 2026. Notice 61a78b0d91244a65b239a1248a80e7af. https://sam.gov/workspace/contract/opp/61a78b0d91244a65b239a1248a80e7af/view

## Points of contact

- LCDR Robert Murray, Program Manager, DARPA/BTO, RAPIID@darpa.mil

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/darpasn2691.